Quantcast

Previous Client

Return to Sector or view our Current Clients.

Untitled Document

Cannabics Pharmaceuticals, Inc. (CNBX)

Cannabics Pharmaceuticals, Inc. (CNBX) was founded in 2012 by a team of experts in the fields of molecular biology, cancer research and pharmacology, who recognized the potential of cannabinoid-based therapies for debilitating and incurable ailments. Through the course of its research, the company’s pharmacology team has amassed valuable knowledge in the development of advanced delivery systems for active cannabinoids that provide improved treatment options for patients wishing to utilize the unique medical properties of the cannabis plant.

Leveraging this expertise and knowledge, Cannabics Pharmaceuticals has created a wide range of solutions for standardized, reproducible and easily administered medical cannabis therapies. The company’s flagship product, Cannabics SR, contains a pure concentrate of cannabinoids derived from select cannabis strains, embedded in a sophisticated formulation which provides beneficial therapeutic effects for 10-12 hours upon a single oral administration.

The excipients of the proprietary Cannabics SR formulation are all certified food-grade ingredients and are free of artificial additives or chemical substances. Cannabics’ proprietary technologies are developed in certified laboratories and are licensed to certified manufacturers and distributors with adequate licenses in their local territories. Cannabics Pharmaceuticals itself does not manufacture, distribute, dispense or possess any controlled substances, including cannabis and cannabis-based preparations.

Co-founders Dr. Zohar Koren (CEO) and Dr. Eyal Ballan (CTO) guide the company’s operations with vast experience in business and pharmaceutical development, strategic consulting, venture capital, evolutionary and environmental sciences, anti-cancer drug development and molecular biology. Under their leadership, Cannabics Pharmaceuticals continues to develop its genetic and phenotipic database to provide superior treatments for incapacitating ailments for which there is no cure.

Transfer Agent
ClearTrust, LLC
16540 Pointe Village Dr.
Suite 201
Lutz, FL 33558

Investor Relations
QualityStocks
3370 N. Hayden Rd.
Scottsdale, AZ. 85251
480-374-1336

Key Investment Highlights
Cannabinoid-Based Therapies
Progressive Management Team
Meeting Unmet Medical Need

Industry
Sector: Healthcare
Industry: Specialty Pharmaceuticals
Sub-industries: Cannabis Therapeutics

Share Information

 

Additional Resources

 

The QualityStocks
Newsroom

Read the articles covering the biggest movers in the markets today.

Continue

Market
Basics

Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.

Continue

The QualityStocks Daily
Archives

Go back to see our previous newsletters and find out what you might have missed.

Continue